CIDRAP newsletters options
Lefamulin approval was supported by two phase 3 trials involving moxifloxacin.
A study of infants who had bacteremic urinary tract infections (UTIs) indicates that short-course parenteral antibiotic therapy may be considered as a treatment option, a team of US researchers reported today in Pediatrics.
The rate of Ebola cases in the Democratic Republic of the Congo (DRC) outbreak shows a slight decline, with Beni and Mandima still remaining as the main hot spots, according to a weekly outbreak and emergencies report from the World Health Organization (WHO) African regional office that covers cases through Aug 17.
With 21 new cases, 2019 US measles totals rise to 1,203 in 30 states.
With 27 new infections in the past 3 days, the outbreak has grown to 2,888 cases and 1,934 deaths.
Postprescription audit and review showed more promise than preauthorization.
Analysis of a 2015-16 cluster highlights living conditions and healthcare spread.
A study by Italian investigators in Clinical Microbiology and Infection has found that commercial methods for testing carbapenem susceptibility produced widely variable results in a sample of carbapenemase-producing Escherichia coli, with none satisfying the criteria for acceptable antimicrobial susceptibility testing (AST) performance.
A multistate Cyclospora outbreak linked to fresh basil imported from Mexico has sickened 73 more people, increasing the total to 205 infections, the Centers for Disease Control and Prevention (CDC) said in an Aug 15 update.
The outbreak has now grown to 2,861 cases, including 1,913 deaths, as the UN announces more funding.
CARB-X yesterday announced additional funding to expand development of a vaccine against Staphylococcus aureus.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
In new polio developments, Pakistan reported five more wild poliovirus type 1 (WPV1) cases and four African countries reported more circulating vaccine-derived poliovirus type 2 (cVDPV2) cases, including the first in Benin, according to the latest weekly update today from the Global Polio Eradication Initiative (GPEI).
According to the World Health Organization's (WHO) online dashboard, 10 new cases of Ebola have been confirmed in the Democratic Republic of the Congo (DRC), raising the outbreak total to 2,852, and 380 suspected cases are still under investigation.
Fatalities have passed the 1,900 mark, to stand at 1,905, after seven new deaths from the virus were confirmed today.
An analysis of data from routine antibiotic susceptibility testing in 30 European countries shows a strong correlation between the rates of intrinsically antibiotic-resistant bacterial species and the rates of acquired resistance in gram-negative bacterial species, a team of European researchers reported today in Eurosurveillance.
The shorter, simpler regimen with the new drug is poised to improve treatment against a difficult disease and to lower costs.
Burundi yesterday began vaccinating front-line workers against Ebola, part of efforts to prepare for possible Ebola cases, the World Health Organization (WHO) said today in a statement. The country's border with the Democratic Republic of Congo (DRC) is southeast of the main outbreak area, and vaccination with VSV-EBOV began at the Gatumba entry point.
US Sen. Sherrod Brown, D-Ohio, yesterday reintroduced legislation to strengthen the federal government's response to antibiotic resistance.
Earlier the summer, the CDC warned doctors to be alert for AFM cases that seem to rise late summer and fall alongside enterovirus activity.
Also, insecurity flares again in Beni, with suspected ADF attacks and resulting community protests.
